![Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2015/81/5/Images/ijdvl_2015_81_5_540_163800_u1.jpg)
Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology
![Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review | HTML | Acta Dermato-Venereologica Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/html-img/5528/5528_20270.png)
Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review | HTML | Acta Dermato-Venereologica
I wanted to share something pretty awesome with you guys! Almost 2 and a half weeks ago, I received this sirolimus cream in the mail. I have been on the sirolimus pill
![Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962217304413-gr2.jpg)
Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect
![Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient Vasani RJ - Indian J Dermatol Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient Vasani RJ - Indian J Dermatol](https://www.e-ijd.org/articles/2015/60/2/images/IndianJDermatol_2015_60_2_165_152516_f1.jpg)
Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient Vasani RJ - Indian J Dermatol
![Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3767-8/MediaObjects/13063_2019_3767_Fig1_HTML.png)
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text
![Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962217304413-gr4.jpg)
Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex A Randomized Clinica
![Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00387-7/MediaObjects/13555_2020_387_Fig5_HTML.jpg)
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy
![Rapamycin Skin Cream - US Pharmacy that is Selling it (prescription needed) - Rapamycin Longevity News Rapamycin Skin Cream - US Pharmacy that is Selling it (prescription needed) - Rapamycin Longevity News](https://www.rapamycin.news/uploads/default/original/2X/7/7712f90c5a4ddd0354f8e7fac7a25bb847e6618d.jpeg)
Rapamycin Skin Cream - US Pharmacy that is Selling it (prescription needed) - Rapamycin Longevity News
![A) Pre-treatment image; (B) after 3 months of topical 0.1% sirolimus... | Download Scientific Diagram A) Pre-treatment image; (B) after 3 months of topical 0.1% sirolimus... | Download Scientific Diagram](https://www.researchgate.net/publication/362947110/figure/fig1/AS:11431281081099397@1661520270323/A-Pre-treatment-image-B-after-3-months-of-topical-01-sirolimus-ointment-twice.png)
A) Pre-treatment image; (B) after 3 months of topical 0.1% sirolimus... | Download Scientific Diagram
![Frontiers | Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex Frontiers | Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex](https://www.frontiersin.org/files/Articles/490613/fmed-07-00001-HTML/image_m/fmed-07-00001-g002.jpg)